Tag: Belgium

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, yesterday celebrated the grand opening of its new Q1 Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, a Belgium-based contract research organization supporting pharmaceutical companies, … Continued

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that their stability storage business, Q1 Scientific, has opened a new 20,000 sq ft cGMP facility in Belgium, expanding its capacity for environmentally-controlled stability storage services to the pharmaceutical, medical … Continued

Q1 Scientific, which offers environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries, today announced that Cécile Jacoby has been appointed General Manager at the new Q1 Scientific Belgium facility. With more than 25 years of experience in senior strategic and operations roles across pharmaceutical, vaccine, healthcare and cell therapy … Continued

Cambrex today announced the expansion of their stability storage business, Q1 Scientific, which offers environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries.  Q1 Scientific will open a new 20,000 sq ft cGMP facility in Belgium and add an additional 10,000 sq ft at their existing facility in Waterford, Ireland.  The … Continued